Identification of ovarian cancer driver genes by using module network integration of multi-omics data

Interface Focus

Volumn 3, Issue 4, 2013, Pages

  Gevaert, Olivier ^a   Villalobos, Victor ^b   Sikic, Branimir I ^b   Plevritis, Sylvia K ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Copy number; Data integration; DNA methylation; Gene expression; Ovarian cancer

Indexed keywords

EID: 84879436153     PISSN: 20428898     EISSN: 20428901     Source Type: Journal    
DOI: 10.1098/rsfs.2013.0013     Document Type: Article

References (26)

1. Sotiriou C. 2009 Molecular biology in oncology and its influence on clinical practice: gene expression profiling. Ann. Oncol. 20, 10.
2. Pao W et al. 2009 Integration of molecular profiling into the lung cancer clinic. Clin. Cancer Res. 15, 5317-5322. (doi:10.1158/1078-0432.CCR- 09-0913)
3. Gevaert O, De Moor B. 2009 Prediction of cancer outcome using DNA microarray technology: past, present and future. Expert Opin. Med. Diagn. 3, 157-165. (doi:10.1517/17530050802680172)
4. Ciriello G, Cerami E, Sander C, Schultz N. 2011 Mutual exclusivity analysis identifies oncogenic network modules. Genome Res. 22, 398-406. (doi:10.1101/gr.125567.111)
5. Vandin F, Upfal E, Raphael BJ. 2011 De novo discovery of mutated driver pathways in cancer. Genome Res. 22, 375-385. (doi:10.1101/gr. 120477.111)
6. Akavia UD et al. 2010 An integrated approach to uncover drivers of cancer. Cell 143, 1005-1017. (doi:10.1016/j.cell.2010.11.013)
7. Bell D et al. 2011 Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615. (doi:10. 1038/nature10166)
8. Gevaert O, Plevritis S. 2013 Identifying master regulators of cancer and their downstream targets by integrating genomic and epigenomic features, pp. 123-134. Big Island, HI: Pacific Symposium on Biocomputing.
9. Gevaert O, Rao X, Plevritis S. Submitted. MethylMix: identifying DNA methylation-driven genes in cancer.
10. Nicolau M, Tibshirani R, Borresen-Dale AL, Jeffrey SS. 2007 Disease-specific genomic analysis: identifying the signature of pathologic biology. Bioinformatics 23, 957-965. (doi:10.1093/ bioinformatics/btm033)
11. Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. 2011 GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41. (doi:10.1186/ gb-2011-12-4-r41)
12. Taylor BS, Barretina J, Socci ND, Decarolis P, Ladanyi M, Meyerson M, Singer S, Sander C. 2008 Functional copy-number alterations in cancer. PLoS ONE 3, e3179. (doi:10.1371/journal.pone.0003179)
13. Lee S-I, Dudley AE, Drubin D, Silver P, Krogan N, Pe'er D, Koller D. 2009 Learning a prior on regulatory potential from eQTL data. PLoS Genet. 5, e1000358. (doi:10.1371/journal.pgen.1000358)
14. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, Altman RB. 2001 Missing value estimation methods for DNA microarrays. Bioinformatics 17, 520-525. (doi:10. 1093/bioinformatics/17.6.520)
15. Johnson WE, Li C, Rabinovic A. 2007 Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127. (doi:10.1093/biostatistics/kxj037)
16. Tone AA, Begley H, Sharma M, Murphy J, Rosen B, Brown TJ, Shaw PA. 2008 Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma. Clin. Cancer Res. 14, 4067-4078. (doi:10.1158/1078-0432.CCR-07-4959)
17. Kim J, Coffey DM, Creighton CJ, Yu Z, Hawkins SM, Matzuk MM. 2012 High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc. Natl Acad. Sci. USA 109, 3921-3926. (doi:10.1073/ pnas.1117135109)
18. Subramanian A et al. 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550. (doi:10. 1073/pnas.0506580102)
19. Culhane AC et al. 2010 GeneSigDB-a curated database of gene expression signatures. Nucleic Acids Res. 38, D716-D725. (doi:10.1093/nar/ gkp1015)
20. Lachmann A, Xu H, Krishnan J, Berger SI, Mazloom AR, Ma'ayan A. 2010 ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 2438-2444. (doi:10.1093/bioinformatics/btq466)
21. Benjamini Y, Hochberg Y. 1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289-300.
22. Tibshirani R, Hastie T, Friedman J. 2010 Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1-22.
23. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. 2004 A census of human cancer genes. Nat. Rev. Cancer 4, 177-183. (doi:10.1038/nrc1299)
24. Velasco-Velazquez M, Jiao X, De La Fuente M, Pestell TG, Ertel A, Lisanti MP, Pestell RG. 2012 CCR5 antagonist blocks metastasis of basal breast cancer cells. Cancer Res. 72, 3839-3850. (doi:10.1158/ 0008-5472.CAN-11-3917)
25. Bignotti E et al. 2007 Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes. Am. J. Obstet. Gynecol. 196, 245.e1-245.e11. (doi:10.1016/j.ajog. 2006.10.874)
26. McAuliffe SM et al. 2012 Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc. Natl Acad. Sci. USA 109, E2939-E2948. (doi:10.1073/pnas. 1206400109)